SCHEMBL5824932

SCHEMBL5824932

Cc1ccccc1OCCSc1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
LMNA P02545 3/20 0.52
HPGD P15428 1/20 0.52
GAA P10253 3/20 0.52
MAPT P10636 5/20 0.50
PKM P14618 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
AR P10275 1/20 0.50
PDPK1 O15530 2/20 0.45
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20005776 0.87 MAPT (0.55) KMT2AL3MBTL1LMNAHPGDGAA
SCHEMBL12301165 0.86 L3MBTL1 (0.57) KMT2AL3MBTL1LMNAHPGDGAA
SCHEMBL9768856 0.83 L3MBTL1 (0.51) KMT2AL3MBTL1LMNAHPGDGAA
SCHEMBL5824607 0.82 SCN8A (0.52) KMT2AL3MBTL1LMNAMAPTAR
SCHEMBL5824925 0.81 L3MBTL1 (0.61) KMT2AL3MBTL1HPGDGAAMAPT
SCHEMBL5825555 0.81 KDM4E (0.47) KMT2AL3MBTL1LMNAHPGDGAA
SCHEMBL5825422 0.81 RAB9A (0.54) KMT2AL3MBTL1LMNAHPGDGAA
SCHEMBL5825350 0.80 LMNA (0.47) KMT2AL3MBTL1LMNAHPGDGAA
SCHEMBL10707303 0.78 TDP1 (0.63) KMT2AL3MBTL1LMNAGAAMAPT
SCHEMBL9770237 0.78 KDM4E (0.57) KMT2ALMNAHPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KMT2A 2022/4885L3MBTL1 1545/4885LMNA 1836/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KMT2A 2006/4885L3MBTL1 1895/4885LMNA 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.